CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-02 | ORBIMED ADVISORS LLC 10% owner | Sale | −445,086 | $26.00 | $11.6M | 2,113,877 |
| 2020-03-02 | ORBIMED ADVISORS LLC 10% owner | Sale | −38,808 | $26.00 | $1.0M | 0 |
| 2020-02-14 | King Robert Chief Development Officer | Sale | −4,668 | $29.09 | $136K | 502,649 |
| 2020-02-14 | King Robert Chief Development Officer | Sale | −10,332 | $29.77 | $308K | 492,317 |
| 2020-02-14 | Paul Robert Chief Medical Officer | Sale | −3,000 | $29.07 | $87K | 270,719 |
| 2020-02-14 | Paul Robert Chief Medical Officer | Sale | −7,000 | $29.74 | $208K | 263,719 |
| 2020-02-07 | Oney Sabah Chief Business Officer | Sale | −19,900 | $35.03 | $697K | 573,918 |
| 2020-02-07 | Yu Calvin Vice President, Finance | Option exercise | +2,825 | $8.16 | $23K | 127,319 |
| 2020-02-07 | Yu Calvin Vice President, Finance | Option exercise | +7,400 | $10.14 | $75K | 134,719 |
| 2020-02-07 | Yu Calvin Vice President, Finance | Sale | −24,033 | $35.02 | $842K | 110,686 |
| 2020-02-07 | Yu Calvin Vice President, Finance | Option exercise · Stock Option (right to buy) | −2,825 | 32,538 | ||
| 2020-02-07 | Yu Calvin Vice President, Finance | Option exercise · Stock Option (right to buy) | −7,400 | 21,875 | ||
| 2020-02-06 | Yu Calvin Vice President, Finance | Option exercise | +1,096 | $8.16 | $9K | 126,390 |
| 2020-02-06 | Yu Calvin Vice President, Finance | Option exercise | +725 | $10.14 | $7K | 127,115 |
| 2020-02-06 | Yu Calvin Vice President, Finance | Sale | −2,621 | $35.00 | $92K | 124,494 |
| 2020-02-06 | Yu Calvin Vice President, Finance | Option exercise · Stock Option (right to buy) | −1,096 | 35,363 | ||
| 2020-02-06 | Yu Calvin Vice President, Finance | Option exercise · Stock Option (right to buy) | −725 | 29,275 | ||
| 2020-02-06 | Oney Sabah Chief Business Officer | Sale | −100 | $35.00 | $4K | 593,818 |
| 2020-02-05 | Paul Robert Chief Medical Officer | Option exercise | +10,000 | $8.16 | $82K | 283,719 |
| 2020-02-05 | Paul Robert Chief Medical Officer | Sale | −10,000 | $32.10 | $321K | 273,719 |
Page 26 of 36 · 702 trades